If you have any question, please feel free to email us. We will touch with you as soon as possible.
ERLEADA is indicated for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC) in adult patients at high risk of metastasis. For R&D purposes only.
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Generic name | Apalutamide Tablets |
Trade name | ERLEADA |
Specification | 60mg |
Main ingredients | Apalutamide |
Appearance |
This product is pale yellowish green to grayish green oval film coated with "AR60\" inscribed on one side. After removing the coating, it appears white to white or yellowish. |
MA Holder | Janssen-Cilag International NV |
Manufacturer | Janssen Ortho, LLC |
Product Type | Reference Listed Drug |
Indications: ERLEADA is indicated for the treatment of non-metastatic castration-resistant prostate cancer (NM-CRPC) in adult patients at high risk of metastasis.
For more details,pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: ERLEADA 60mg Apalutamide Tablets Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Olanzapine Tablets, Argatroban Injection, Reference Listed Drugs, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Adefovir Dipivoxil Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China